Offstream
news

The Kyrgyzstan Health Ministry announces that the country plans to purchase doses of the Johnson & Johnson COVID-19 vaccine, as well as around 100,800 doses of the Moderna COVID-19 vaccine.
2022-02-25

Johnson & Johnson officially suspends production of its COVID-19 vaccine. It says production will likely resume later, and that millions of doses remain stocked for distribution per earlier agreements.
2022-02-9

The Johnson & Johnson vaccine will resume rollouts in Europe.
2021-04-20

The Marshall Islands reaches an adult population vaccination rate of nearly 75%. After completing the urban areas, the Ministry of Health and Human Services plans to distribute Moderna and Johnson & Johnson vaccines to the most remote islands of the country to vaccinate the rest of the population. The vaccines were provided as a donation by the United States.
2021-04-13

The United States suspends the use of the Johnson & Johnson vaccine following concerns of blood clots.
2021-04-13

California Governor Gavin Newsom receives the Johnson & Johnson vaccine.
2021-04-1

The Biden administration announces that the United States is expected to receive 11 million doses of the vaccine produced by Johnson & Johnson.
2021-03-26

New York Governor Andrew Cuomo receives the Johnson & Johnson vaccine.
2021-03-17

Johnson & Johnson's single-shot COVID-19 vaccine candidate meets the standards for emergency use authorization, according to analysis from a committee within the FDA, though formal authorization will not be determined until February 26. The vaccine is 66% effective in combating the virus and can be stored in normal refrigerators.
2021-02-24

AstraZeneca and Johnson & Johnson resume their Phase III trials in the United States for a COVID-19 vaccine after previously pausing them as a result of complications with some volunteers.
2020-10-23